Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Next-Generation Coronary Stent Start-Ups: Making a Difference in a Mature Market

This article was originally published in Start Up

Executive Summary

Which kinds of innovations make for incremental enhancements in the hands of large companies and which are meaningful enough to sustain a venture-backed start-up company? In a mature market for coronary stents dominated by large companies, start-ups developing new stents need to find the answers. Areas of innovation fall into four basic categories: improving stent safety and biocompatibility, avoiding the need for dual antiplatelet therapy, enhancing deliverability, and introducing specialty stents for complex vessels. Three companies profiled here have a plan for taking sufficient market share, reducing risk, and rewarding investors.
Advertisement

Related Content

The Future of Drug-Eluting Stents Part I: Novel Next-Generation Designs
Stent Market Doldrums Push Interest Elsewhere
The Future of Drug-Eluting Stents Part I: Novel Next-Generation Designs
Boston Scientific Looks to Next-Generation DES with Labcoat Deal
Vascular Access Closure Ten Years Later: Why Start-Ups Can't Seal the Deal
Vascular Access Closure Ten Years Later: Why Start-Ups Can't Seal the Deal
Xtent and the Next DES Boom
OrbusNeich: Tissue Engineering Meets Coronary Stents
CardioMind: Big Solutions to Small Problems
Labcoat: Less is more in Next Generation Drug-Eluting Stents

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT037636

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel